• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏典型生化表现的脑腱黄瘤病的家族变异性

Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings.

作者信息

Guenzel Adam J, DeBarber Andrea, Raymond Kimiyo, Dhamija Radhika

机构信息

Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA.

Department of Chemical Physiology and Biochemistry Oregon Health and Science University Portland Oregon USA.

出版信息

JIMD Rep. 2021 Jan 8;59(1):3-9. doi: 10.1002/jmd2.12197. eCollection 2021 May.

DOI:10.1002/jmd2.12197
PMID:33977023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8100391/
Abstract

Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive disorder of bile acid synthesis caused by pathogenic variants in the gene encoding the mitochondrial enzyme sterol 27-hydroxylase. Patients with CTX can present with a wide range of symptoms, but most often have evidence of tendon xanthomas along with possible cataracts, atherosclerosis, or neurological dysfunction. Regardless of clinical phenotype, CTX patients typically exhibit levels of cholestanol and bile acid precursors in the circulation that are many fold increased over normal control concentrations. Here we report two siblings, one with the rare spinal xanthomatosis phenotype and the other with a very mild form of CTX manifesting as minor tendon xanthomatosis and gastrointestinal complaints who both carry compound heterozygous variants in : NM_000784.3: c.410G > A (p.Arg137Gln) and c.1183C > T (p.Arg395Cys). However, biochemical analysis of these patients revealed normal levels of serum cholestanol and relatively mild elevations of the bile acid precursors 7α-hydroxy-4-cholesten-3-one and 7α,12α-dihydroxy-4-cholesten-3-one. The atypical biochemical presentation of these cases represents a diagnostic challenge for a disorder once thought to have a sensitive biomarker in cholestanol and highlight the need for thorough investigation of patients with symptomatology consistent with CTX that includes bile acid precursor biochemical testing and molecular analysis.

摘要

脑腱黄瘤病(CTX)是一种罕见的常染色体隐性胆汁酸合成障碍疾病,由编码线粒体酶固醇27 - 羟化酶的基因突变引起。CTX患者可出现多种症状,但最常见的是有肌腱黄瘤,同时可能伴有白内障、动脉粥样硬化或神经功能障碍。无论临床表型如何,CTX患者循环中的胆甾烷醇和胆汁酸前体水平通常比正常对照浓度高出许多倍。在此,我们报告一对兄弟姐妹,其中一人患有罕见的脊柱黄瘤病表型,另一人患有非常轻微的CTX形式,表现为轻微的肌腱黄瘤和胃肠道不适,他们均携带复合杂合变异:NM_000784.3: c.410G>A(p.Arg137Gln)和c.1183C>T(p.Arg395Cys)。然而,对这些患者的生化分析显示血清胆甾烷醇水平正常,胆汁酸前体7α - 羟基 - 4 - 胆甾烯 - 3 - 酮和7α,12α - 二羟基 - 4 - 胆甾烯 - 3 - 酮仅有相对轻微的升高。这些病例的非典型生化表现对一种曾被认为在胆甾烷醇中有敏感生物标志物的疾病构成了诊断挑战,并凸显了对有与CTX相符症状的患者进行全面调查的必要性,这包括胆汁酸前体生化检测和分子分析。

相似文献

1
Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings.缺乏典型生化表现的脑腱黄瘤病的家族变异性
JIMD Rep. 2021 Jan 8;59(1):3-9. doi: 10.1002/jmd2.12197. eCollection 2021 May.
2
Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.基因和临床确诊的非典型脑腱黄瘤病,伴有正常胆甾烷醇和胆汁酸前体及胆汁醇显著升高。
J Clin Lipidol. 2024 May-Jun;18(3):e465-e476. doi: 10.1016/j.jacl.2024.03.004. Epub 2024 Mar 15.
3
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene.一例伴有脊髓受累且无肌腱黄色瘤的脑腱性黄瘤病:CYP27A1基因新突变的鉴定
Acta Neurol Belg. 2021 Apr;121(2):561-566. doi: 10.1007/s13760-019-01267-4. Epub 2019 Dec 24.
4
A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.一例患有大量黄瘤但血清胆甾烷醇水平无显著升高的脑腱性黄瘤病。
J Clin Lipidol. 2023 Nov-Dec;17(6):834-838. doi: 10.1016/j.jacl.2023.09.008. Epub 2023 Sep 17.
5
Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.伴有CYP27A1基因新突变的迟发性脑腱黄瘤病
Intern Med. 2018 Jun 1;57(11):1611-1616. doi: 10.2169/internalmedicine.0120-17. Epub 2018 Feb 9.
6
Cerebrotendinous Xanthomatosis脑腱黄瘤病
7
Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.脑腱黄瘤病:一种胆汁酸合成的先天性错误,具有明确的突变,但仍然具有挑战性。
Biochem Biophys Res Commun. 2010 May 21;396(1):46-9. doi: 10.1016/j.bbrc.2010.02.140.
8
Novel splice-affecting variants in CYP27A1 gene in two Chilean patients with Cerebrotendinous Xanthomatosis.两名患有脑腱黄瘤病的智利患者中CYP27A1基因的新型剪接影响变体。
Genet Mol Biol. 2015 Mar;38(1):30-6. doi: 10.1590/S1415-475738120140087. Epub 2014 Mar 17.
9
Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports.脑腱黄瘤病,一种具有不同神经症状的代谢性疾病:两例病例报告
Metab Brain Dis. 2016 Oct;31(5):1185-8. doi: 10.1007/s11011-016-9841-y. Epub 2016 May 26.
10
Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report.CYP27A1 基因突变致脑腱黄瘤病日本家系 2 例临床表型差异:病例报告
BMC Neurol. 2022 May 25;22(1):193. doi: 10.1186/s12883-022-02711-4.

引用本文的文献

1
Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review.脑腱黄瘤病脂质异常的病理生理学与治疗:一项综合综述
Brain Sci. 2023 Jun 22;13(7):979. doi: 10.3390/brainsci13070979.
2
Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis.脑腱性黄瘤病的等位基因流行率和地理分布。
Orphanet J Rare Dis. 2023 Jan 17;18(1):13. doi: 10.1186/s13023-022-02578-1.
3
Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study.诊治和管理脑腱黄瘤病(CTX)患者的专家意见:一项改良 Delphi 研究。
Orphanet J Rare Dis. 2021 Aug 6;16(1):353. doi: 10.1186/s13023-021-01980-5.

本文引用的文献

1
Teaching NeuroImages: Spinal xanthomatosis: A misdiagnosed, treatable cause of progressive myelopathy.
Neurology. 2020 Sep 15;95(11):e1615-e1616. doi: 10.1212/WNL.0000000000010194. Epub 2020 Jul 7.
2
Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spots.针对脑腱黄瘤病的新生儿筛查:使用 32000 份新生儿干血斑进行生物标志物研究的结果。
Genet Med. 2020 Oct;22(10):1606-1612. doi: 10.1038/s41436-020-0846-x. Epub 2020 Jun 10.
3
Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment.对脑腱性黄瘤病进行新生儿筛查是早期识别和治疗的方法。
J Lipid Res. 2018 Nov;59(11):2214-2222. doi: 10.1194/jlr.M087999. Epub 2018 Aug 22.
4
Prominent Tendon Xanthomas and Abdominal Aortic Aneurysm Associated with Cerebrotendinous Xanthomatosis Identified Using Whole Exome Sequencing.利用全外显子组测序鉴定出与脑腱黄瘤病相关的显著肌腱黄瘤和腹主动脉瘤
Intern Med. 2018 Apr 15;57(8):1119-1122. doi: 10.2169/internalmedicine.9687-17. Epub 2017 Dec 21.
5
Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment.脑弥散张量成像在脑腱性黄瘤病治疗后发生改变。
J Neurol. 2018 Feb;265(2):388-393. doi: 10.1007/s00415-017-8711-9. Epub 2017 Dec 19.
6
Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis.脑腱黄瘤病:早发且常见于孤独症谱系障碍。
J Inherit Metab Dis. 2018 Jul;41(4):641-646. doi: 10.1007/s10545-017-0086-7. Epub 2017 Sep 11.
7
Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families.中国人家族性脑腱黄瘤病患者的临床及分子遗传学特征。
Metab Brain Dis. 2017 Oct;32(5):1609-1618. doi: 10.1007/s11011-017-0047-8. Epub 2017 Jun 17.
8
Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood.脑腱性黄瘤病的自然病史:一种在成年期确诊的儿科疾病。
Orphanet J Rare Dis. 2016 Apr 16;11:41. doi: 10.1186/s13023-016-0419-x.
9
Late-onset spinal form xanthomatosis without brain lesion: a case report.无脑部病变的迟发性脊髓型黄瘤病:一例报告
BMC Neurol. 2016 Feb 9;16:21. doi: 10.1186/s12883-016-0542-2.
10
Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes.通过对约60000份人类外显子组的分析揭示的脑腱黄瘤病明显诊断不足。
Mol Genet Metab. 2015 Dec;116(4):298-304. doi: 10.1016/j.ymgme.2015.10.010. Epub 2015 Oct 26.